INMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 147.3% based on the discounted cash flow analysis.
| Market cap | $853.59 Million |
|---|---|
| Enterprise Value | $477.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.45 |
| Beta | 1.87 |
| Outstanding Shares | 58,903,000 |
| P/E Ratio | 11.88 |
|---|---|
| PEG | -32.83 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 1.49 |
| Enterprise Value to Revenue | 1.27 |
| Enterprise Value to EBIT | 6.03 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.1573▲ 10.04% |
|---|---|
| Total Calls | 455,900▲ 24.05% |
| Total Puts | 983,500▲ 30.11% |
Holdings and activity of institutional investors.
| Ownership % | 51.01%▼ 1.87% |
|---|---|
| Total Invested | $520.73M▲ 13.58% |
| Investors Holding | 204▲ 2.00% |
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...